9.06離岸人民幣0.08(0.89%)
2025/05/22更新
績效 / 1月2.58%
3月12.52%
1年16.31%
晨星評等-
- 1.現金13.35%
- 2.股票36.34%
- 3.債券0.00%
- 4.其他50.31%
- 1.美國50.63%
- 2.歐洲不包含歐元區22.21%
- 3.日本14.13%
- 1.Novo Nordisk AS Class B7.67%
- 2.Chugai Pharmaceutical Co Ltd7.39%
- 3.Amgen Inc7.39%
- 4.Eli Lilly and Co7.34%
- 5.Gilead Sciences Inc7.31%
- 6.Roche Holding AG7.30%
- 7.AbbVie Inc4.97%
- 8.Zealand Pharma AS4.44%
- 9.Veeva Systems Inc Class A4.12%
- 10.Otsuka Holdings Co Ltd3.83%
- 1.現金13.35%
- 2.股票36.34%
- 3.債券0.00%
- 4.其他50.31%
- 1.美國50.63%
- 2.歐洲不包含歐元區22.21%
- 3.日本14.13%
- 1.Novo Nordisk AS Class B7.67%
- 2.Chugai Pharmaceutical Co Ltd7.39%
- 3.Amgen Inc7.39%
- 4.Eli Lilly and Co7.34%
- 5.Gilead Sciences Inc7.31%
- 6.Roche Holding AG7.30%
- 7.AbbVie Inc4.97%
- 8.Zealand Pharma AS4.44%
- 9.Veeva Systems Inc Class A4.12%
- 10.Otsuka Holdings Co Ltd3.83%